Mizuho Securities USA’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Buy
11,558
+2,686
+30% +$514K 0.04% 379
2026
Q1
$1.63M Sell
8,872
-1,810
-17% -$334K 0.04% 434
2025
Q4
$1.95M Buy
10,682
+4
+0% +$653 0.03% 427
2025
Q3
$1.41M Buy
10,678
+548
+5% +$74.1K 0.03% 509
2025
Q2
$1.27M Sell
10,130
-1,590
-14% -$198K 0.03% 500
2025
Q1
$1.6M Sell
11,720
-2,091
-15% -$299K 0.03% 438
2024
Q4
$2.11M Buy
13,811
+4,366
+46% +$736K 0.04% 401
2024
Q3
$1.83M Sell
9,445
-1,777
-16% -$372K 0.04% 370
2024
Q2
$2.6M Buy
+11,222
New +$2.44M 0.06% 314
2016
Q4
Sell
-115,200
Closed -$36.1M 204
2016
Q3
$36.1M Buy
+115,200
New +$34.1M 3% 6
2015
Q3
Sell
-739
Closed -$299K 132
2015
Q2
$299K Sell
739
-19,709
-96% -$7.91M 0.04% 148
2015
Q1
$8.63M Buy
20,448
+13,395
+190% +$5.28M 1.11% 21
2014
Q4
$2.39M Buy
7,053
+2,939
+71% +$951K 0.24% 65
2014
Q3
$1.36M Buy
+4,114
New +$1.36M 0.16% 55
2014
Q1
Sell
-28,474
Closed -$7.97M 28
2013
Q4
$7.97M Buy
28,474
+7,981
+39% +$2.06M 0.66% 37
2013
Q3
$4.93M Sell
20,493
-3,520
-15% -$788K 0.31% 44
2013
Q2
$5.17M Buy
+24,013
New +$5.13M 0.26% 42

Other funds holding BIIB

Mizuho Securities USA's BIIB Position: Q2 2026 in Review

Mizuho Securities USA increased its Biogen (BIIB) stake by 30% in Q2 2026, buying an estimated $514K and bringing the position to 11,558 shares worth $2.5M. The position accounts for 0.04% of the portfolio, ranked #379.

Mizuho Securities USA first reported a position in BIIB in Q2 2013 and has held it in 17 quarters since. The position peaked at $36.1M in Q3 2016. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Mizuho Securities USA held 11,558 shares of Biogen worth $2.5M as of Q2 2026.
  • Mizuho Securities USA bought 2,686 Biogen shares in Q2 2026, an estimated $514K.
  • Biogen made up 0.04% of Mizuho Securities USA's portfolio in Q2 2026, its #379 holding.
  • Mizuho Securities USA first reported a position in Biogen in Q2 2013 and has held it in 17 quarters since.
  • Mizuho Securities USA's Biogen position peaked at $36.1M in Q3 2016.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.